ArticleJournal of Cancer2025

Identification and validation of the PARP inhibitor-related gene KANK3 for predicting prognosis and immunotherapeutic response in prostate cancer.

Yan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.